Company Analysis

Pluri Inc. (PLUR)

Nasdaq: PLUR · Biological Products, (No Diagnostic Substances) · Haifa · filing with the SEC since 2001
Grade4.2
◀ Past 3.6● Present 3.7▶ Future 5.0
1 est.

Who runs Pluri Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Yanay Yaky
Chief Executive Officer. First filing Jun 2007, latest Dec 8, 2025, 4 filings in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
20 people on the record since 2006
Officerssales are open-market, Oct 27, 2025 to Oct 27, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Yanay YakyChief Executive OfficerJun 2007Dec 8, 2025none
Aberman ZamiExecutive ChairmanJan 2006Dec 8, 2025none
Zalts LiatChief Financial OfficerSep 2024Dec 8, 2025none
Directorssales are open-market, Oct 27, 2025 to Oct 27, 2026
NameRoleFirst filingLatest filingSales, 12 months
Manieu Alexandre WeinsteindirectorFeb 2025Oct 27, 2026none
Shorrer DorondirectorJan 2006Aug 24, 2026none
Chutzpah Holdings LtddirectorFeb 2025May 4, 2026none
Ajchenbaum EitandirectorSep 2025Dec 8, 2025none
Levi Rami AvrahamdirectorJan 2021Dec 8, 2025none
Shemesh-Rasmussen MaitaldirectorJan 2021Dec 8, 2025none
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PLUR · research, not advice